{"id":5751,"date":"2022-09-06T07:30:42","date_gmt":"2022-09-06T11:30:42","guid":{"rendered":"https:\/\/bridge-bio.local\/news\/auto-draft\/"},"modified":"2023-02-17T10:05:17","modified_gmt":"2023-02-17T15:05:17","slug":"bridgebio-pharma-to-participate-in-september-investor-events","status":"publish","type":"post","link":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/","title":{"rendered":"BridgeBio Pharma to Participate in September Investor Events"},"content":{"rendered":"<p align=\"left\"><strong>PALO ALTO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) &#8212;<\/strong> BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of the management team will participate in the following upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li><strong>Citi\u2019s 17th Annual BioPharma Conference, Boston, MA:<\/strong>\u00a0September 7<sup>th<\/sup>\u00a0at\u00a08:50 am ET<\/li>\n<li><strong>Morgan Stanley Global Healthcare Conference, New York, NY:\u00a0<\/strong>September 13<sup>th<\/sup>\u00a0at 7:20 am ET<\/li>\n<li><strong>Baird Global Healthcare Conference, New York, NY:<\/strong>\u00a0September 14<sup>th<\/sup>\u00a0at 12:50 pm ET<\/li>\n<li><strong>H.C. Wainwright 24th Annual Global Investment Conference, New York, NY:\u00a0<\/strong>September 14<sup>th<\/sup>\u00a0at 11:30 am ET<\/li>\n<li><strong>Cantor Fitzgerald\u2019s Genetic Medicines Conference, New York, NY:<\/strong>\u00a0September 15<sup>th<\/sup><\/li>\n<li><strong>Jefferies Genetic Cell and Medicine Summit, New York, NY:<\/strong>\u00a0September 29<sup>th<\/sup><\/li>\n<li><strong>Biotech South Beach, Miami, FL:\u00a0<\/strong>September 29<sup>th<\/sup><\/li>\n<\/ul>\n<p>To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents\u201d page within the Investors section of the BridgeBio website at\u00a0<a href=\"https:\/\/investor.bridgebiodev.wpengine.com\/\" target=\"_blank\" rel=\"nofollow noopener\"><u>https:\/\/investor.bridgebiodev.wpengine.com<\/u><\/a>. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.<\/p>\n<p><strong>About BridgeBio Pharma, Inc.<\/strong><br \/>\nBridgeBio Pharma, Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio\u2019s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit\u00a0<a href=\"http:\/\/bridgebio.com\/\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>bridgebiodev.wpengine.com<\/u><\/strong><\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.linkedin.com\/company\/bridgebio\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>LinkedIn<\/u><\/strong><\/a>\u00a0and\u00a0<a href=\"https:\/\/twitter.com\/BridgeBioPharma\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>Twitter<\/u><\/strong><\/a>.<\/p>\n<p><strong>BridgeBio Contact:<\/strong><br \/>\nGrace Rauh<br \/>\n<a href=\"mailto:Grace.rauh@bridgebiodev.wpengine.com\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>Grace.rauh@bridgebiodev.wpengine.com<\/u><\/strong><\/a><br \/>\n(917) 232-5478<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of the management team will participate in the following upcoming investor conferences: Citi\u2019s 17th Annual BioPharma Conference, Boston, MA:\u00a0September 7th\u00a0at\u00a08:50 am ET Morgan [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5751","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":{"people":false,"external_link":"","presentation":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BridgeBio Pharma to Participate in September Investor Events - BridgeBio<\/title>\n<meta name=\"description\" content=\"BridgeBio announced that members of the management team will participate in 7 upcoming investor conferences. Learn more today.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BridgeBio Pharma to Participate in September Investor Events - BridgeBio\" \/>\n<meta property=\"og:description\" content=\"BridgeBio announced that members of the management team will participate in 7 upcoming investor conferences. Learn more today.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"BridgeBio\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-06T11:30:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-17T15:05:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Holly Condon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:site\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Holly Condon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/\",\"url\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/\",\"name\":\"BridgeBio Pharma to Participate in September Investor Events - BridgeBio\",\"isPartOf\":{\"@id\":\"https:\/\/bridgebio.com\/#website\"},\"datePublished\":\"2022-09-06T11:30:42+00:00\",\"dateModified\":\"2023-02-17T15:05:17+00:00\",\"author\":{\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/e56e9128cd840531b0acdca992cb1fca\"},\"description\":\"BridgeBio announced that members of the management team will participate in 7 upcoming investor conferences. Learn more today.\",\"breadcrumb\":{\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bridgebio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio Pharma to Participate in September Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/bridgebio.com\/#website\",\"url\":\"https:\/\/bridgebio.com\/\",\"name\":\"BridgeBio\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/bridgebio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/e56e9128cd840531b0acdca992cb1fca\",\"name\":\"Holly Condon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4465d7631588f41599cacc7a8380e613?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4465d7631588f41599cacc7a8380e613?s=96&d=mm&r=g\",\"caption\":\"Holly Condon\"},\"url\":\"https:\/\/bridgebio.com\/author\/hcondon\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BridgeBio Pharma to Participate in September Investor Events - BridgeBio","description":"BridgeBio announced that members of the management team will participate in 7 upcoming investor conferences. Learn more today.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"BridgeBio Pharma to Participate in September Investor Events - BridgeBio","og_description":"BridgeBio announced that members of the management team will participate in 7 upcoming investor conferences. Learn more today.","og_url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/","og_site_name":"BridgeBio","article_published_time":"2022-09-06T11:30:42+00:00","article_modified_time":"2023-02-17T15:05:17+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png","type":"image\/png"}],"author":"Holly Condon","twitter_card":"summary_large_image","twitter_creator":"@BridgeBioPharma","twitter_site":"@BridgeBioPharma","twitter_misc":{"Written by":"Holly Condon","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/","url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/","name":"BridgeBio Pharma to Participate in September Investor Events - BridgeBio","isPartOf":{"@id":"https:\/\/bridgebio.com\/#website"},"datePublished":"2022-09-06T11:30:42+00:00","dateModified":"2023-02-17T15:05:17+00:00","author":{"@id":"https:\/\/bridgebio.com\/#\/schema\/person\/e56e9128cd840531b0acdca992cb1fca"},"description":"BridgeBio announced that members of the management team will participate in 7 upcoming investor conferences. Learn more today.","breadcrumb":{"@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bridgebio.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio Pharma to Participate in September Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/bridgebio.com\/#website","url":"https:\/\/bridgebio.com\/","name":"BridgeBio","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bridgebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/e56e9128cd840531b0acdca992cb1fca","name":"Holly Condon","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4465d7631588f41599cacc7a8380e613?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4465d7631588f41599cacc7a8380e613?s=96&d=mm&r=g","caption":"Holly Condon"},"url":"https:\/\/bridgebio.com\/author\/hcondon\/"}]}},"_links":{"self":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/5751"}],"collection":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/comments?post=5751"}],"version-history":[{"count":0,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/5751\/revisions"}],"wp:attachment":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/media?parent=5751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/categories?post=5751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/tags?post=5751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}